Advances in the Treatment of Patients with Systemic Lupus Erythematosus: Leveraging its Pathogenic Pathways to Improve Outcomes

Advances in the Treatment of Patients with Systemic Lupus Erythematosus: Leveraging its Pathogenic Pathways to Improve Outcomes is organized by Med Learning Group.

Release Date: March 30, 2022
Expiration Date: March 30, 2023

Learning Objectives:
• Describe the immune cells and proinflammatory proteins that represent therapeutic targets in SLE including BAFF, type 1 interferon, and cytokines associated with JAK/STAT signaling
• Explain how dysregulated innate and adaptive immune responses lead to specific clinical manifestations and disease consequences in patients with SLE
• Evaluate the safety and efficacy of new and emerging SLE therapies that target its pathogenetic pathways
Select treatments for patients with SLE based on their pathogenic rationale